Header Logo

Connection

Robert Mannel to Neoplasms, Hormone-Dependent

Back to Details
This is a "connection" page, showing publications Robert Mannel has written about Neoplasms, Hormone-Dependent.
Robert Mannel
Connection Strength
0.075
Neoplasms, Hormone-Dependent
  1. Phase II trial of cetuximab and carboplatin in relapsed platinum-sensitive ovarian cancer and evaluation of epidermal growth factor receptor expression: a Gynecologic Oncology Group study. Gynecol Oncol. 2008 Mar; 108(3):493-9.
    View in: PubMed
    Score: 0.075
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.